PODESTA GROUP, INC. for AMGEN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Economics/Economic Development ECN
Economic policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ISRAEL S KLEIN New | Comm. Director, Sen. Charles Schumer |
Health Issues HCR
Prescription Drug User Fee Act reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
Medicare/Medicaid MMM
Medicare Part B reimbursement and coverage of dialysis products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
| OSCAR RAMIREZ | — |
Budget/Appropriations BUD
Prescription Drug User Fee Act reauthorization. FY 2011 funding in regards to the FDA. H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.